PortfoliosLab logoPortfoliosLab logo
PLSE vs. NVDA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PLSE vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pulse Biosciences, Inc. (PLSE) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PLSE achieves a 82.01% return, which is significantly higher than NVDA's 15.15% return. Over the past 10 years, PLSE has underperformed NVDA with an annualized return of 19.02%, while NVDA has yielded a comparatively higher 68.84% annualized return.


PLSE

1D
2.92%
1M
24.76%
YTD
82.01%
6M
85.25%
1Y
41.75%
3Y*
57.47%
5Y*
6.15%
10Y*
19.02%

NVDA

1D
-3.62%
1M
8.20%
YTD
15.15%
6M
19.59%
1Y
52.10%
3Y*
76.15%
5Y*
65.05%
10Y*
68.84%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PLSE vs. NVDA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PLSE
Pulse Biosciences, Inc.
82.01%-21.14%42.24%341.88%-81.30%-37.93%77.93%17.02%-51.44%263.08%
NVDA
NVIDIA Corporation
15.15%38.92%171.25%239.02%-50.26%125.48%122.30%76.94%-30.82%81.99%

Correlation

The correlation between PLSE and NVDA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since May 19, 2016

0.17

Fundamentals

Market Cap

PLSE:

$1.69B

NVDA:

$5.24T

EPS

PLSE:

-$1.11

NVDA:

$6.53

PS Ratio

PLSE:

2.24K

NVDA:

20.72

PB Ratio

PLSE:

25.55

NVDA:

26.80

Total Revenue (TTM)

PLSE:

$751.00K

NVDA:

$253.49B

Gross Profit (TTM)

PLSE:

-$684.00K

NVDA:

$187.95B

EBITDA (TTM)

PLSE:

-$73.79M

NVDA:

$192.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PLSE vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PLSE
PLSE Risk / Return Rank: 6363
Overall Rank
PLSE Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
PLSE Sortino Ratio Rank: 6666
Sortino Ratio Rank
PLSE Omega Ratio Rank: 6363
Omega Ratio Rank
PLSE Calmar Ratio Rank: 6464
Calmar Ratio Rank
PLSE Martin Ratio Rank: 6262
Martin Ratio Rank

NVDA
NVDA Risk / Return Rank: 7878
Overall Rank
NVDA Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 7777
Sortino Ratio Rank
NVDA Omega Ratio Rank: 7373
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7979
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PLSE vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pulse Biosciences, Inc. (PLSE) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PLSENVDADifference

Sharpe ratio

Return per unit of total volatility

0.49

1.53

-1.04

Sortino ratio

Return per unit of downside risk

1.57

2.15

-0.58

Omega ratio

Gain probability vs. loss probability

1.19

1.26

-0.07

Calmar ratio

Return relative to maximum drawdown

1.15

2.59

-1.44

Martin ratio

Return relative to average drawdown

2.21

6.36

-4.15

PLSE vs. NVDA - Sharpe Ratio Comparison

The current PLSE Sharpe Ratio is 0.49, which is lower than the NVDA Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of PLSE and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PLSENVDADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.49

1.53

-1.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.06

1.27

-1.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.21

1.39

-1.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.21

0.63

-0.41

Drawdowns

PLSE vs. NVDA - Drawdown Comparison

The maximum PLSE drawdown since its inception was -97.22%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for PLSE and NVDA.


Loading charts...

Drawdown Indicators


PLSENVDADifference

Max Drawdown

Largest peak-to-trough decline

-97.22%

-89.72%

-7.50%

Max Drawdown (1Y)

Largest decline over 1 year

-36.51%

-20.21%

-16.30%

Max Drawdown (3Y)

Largest decline over 3 years

-55.90%

-36.88%

-19.02%

Max Drawdown (5Y)

Largest decline over 5 years

-95.38%

-66.34%

-29.04%

Max Drawdown (10Y)

Largest decline over 10 years

-97.22%

-66.34%

-30.88%

Current Drawdown

Current decline from peak

-43.55%

-8.90%

-34.65%

Average Drawdown

Average peak-to-trough decline

-59.75%

-36.21%

-23.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.04%

8.21%

+10.83%

Volatility

PLSE vs. NVDA - Volatility Comparison

Pulse Biosciences, Inc. (PLSE) has a higher volatility of 28.86% compared to NVIDIA Corporation (NVDA) at 12.53%. This indicates that PLSE's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PLSENVDADifference

Volatility (1M)

Calculated over the trailing 1-month period

28.86%

12.53%

+16.33%

Volatility (6M)

Calculated over the trailing 6-month period

69.05%

25.54%

+43.51%

Volatility (1Y)

Calculated over the trailing 1-year period

84.91%

34.22%

+50.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

97.99%

51.69%

+46.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

91.70%

49.80%

+41.90%

Dividends

PLSE vs. NVDA - Dividend Comparison

PLSE has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


PositionTTM20252024202320222021202020192018201720162015
NVDA
NVIDIA Corporation
0.02%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%
PLSE
Pulse Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PLSE vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Pulse Biosciences, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
401.00K
81.62B
(PLSE) Total Revenue
(NVDA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PLSE and NVDA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PLSE has higher volatility (28.86%) compared to NVDA (12.53%). In terms of maximum drawdown, PLSE dropped -97.22% vs NVDA's -89.72%.

NVDA currently has the higher Sharpe Ratio (1.53 vs 0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PLSE and NVDA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer